Pfizer Inc said on Wednesday it acquired a 15 percent stake in Vivet Therapeutics, as well as an exclusive option to fully acquire it, a deal that will give it access to the French company’s experimental gene therapy...
KKR, CVC, other PE firms bid for Asian hospital business – sources
Columbia Pacific Management’s Asian hospital business has drawn interest from global private equity players including KKR, CVC and Carlyle, in a sale the U.S. investment company sees fetching about $2 billion, sources...
Baring set to acquire health tech co AGS in Rs 2,230cr deal
Buyout investor Baring Private Equity Partners Asia is set to acquire AGS Health, a medical revenue cycle management (RCM) company, in a deal valued at $320 million, or Rs 2,230 crore, people directly aware of the...
SC to hear Daiichi plea on arbitration case against Singh brothers on Thursday
The crucial hearing on ₹3,500 crore arbitration case against former Ranbaxy Ltd promoters Malvinder and Shivinder Singh and Japanese drug makrer Daiichi Sankyo Inc, which is seeking to recover the amount awarded to it...
Everstone picks up strategic stake in Chennai based in-vitro diagnostics firm CPC
Singapore based private equity firm Everstone Capital has picked up a strategic stake in Chennai based manufacturer of in-vitro diagnostic products CPC Diagnostics. Everstone has made this investment through its...
CCI clears Radiant Life Care-Max Healthcare merger
The Competition Commission of India (CCI) has cleared the purposed deal between KKR-backed Radiant Life Care and Max Healthcare. The companies announced the proposed merger in a joint statement in December 2018. The...
Japan’s Fujifilm buys biologics unit from Biogen to boost healthcare business
Japan’s Fujifilm Holdings Corp will buy a drugmaking business from U.S.-based Biogen Inc for about $890 million to try to bolster its healthcare business as growth at its legacy photocopy operations stagnates. The unit...
Australia’s Sigma Healthcare board rejects API takeover bid
Australian pharmacy operator Sigma Healthcare Ltd’s (SIG.AX) board on Wednesday rejected a A$727 million ($514.5 million) takeover bid from Australian Pharmaceutical Industries Ltd (API) (API.AX), saying it was not in...
Britain’s Smith & Nephew to buy Osiris in regenerative products push
Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing...
We’ll be looking at acquisition opportunities in north India: Dr Azad Moopen
After setting up a string of hospitals in Gulf Cooperation Council (GCC) countries and in southern India, one of the largest emerging healthcare chains, Aster DM Healthcare Ltd, is all set to make significant...
‘Gurinder Singh Dhillon used funds from Ranbaxy stake sale to buy real estate’
Businessman Malvinder Singh has alleged that part of the proceeds from the stake sale in Ranbaxy Laboratories Ltd was used by Gurinder Singh Dhillon, the spiritual head of Radha Soami Satsang Beas, to buy real estate...
Biogen to buy Nightstar Therapeutics in $800 mln cash deal
Biogen Inc said on Monday it will buy Nightstar Therapeutics Plc for about $800 million in cash as the company looks to tap into a potentially lucrative gene therapy market. Biogen’s offer of $25.50 per share...
